[Risk factors of pulmonary cavitation in COVID-19 pneumonia].

Z G Berikkhanov Sergey N Avdeev G V Nekludova E A Tarabrin K R Eminova N N Khlistunova

Published in: Khirurgiia (2024)

The risk of pulmonary cavitation in COVID-19 is directly related to advanced lung damage and untimely or absent biological therapy with IL-6 inhibitors. Pulmonary cavitation in COVID-19 is not a typical manifestation of disease and can be caused by some factors: fungal infection, secondary bacterial infection, tuberculosis and pulmonary infarction. Further study of this problem is required to develop diagnostic algorithms and treatment tactics.

Keyphrases

coronavirus disease
pulmonary hypertension
sars cov
risk factors
machine learning
mycobacterium tuberculosis
oxidative stress
stem cells
intensive care unit
deep learning
hepatitis c virus
pulmonary tuberculosis
hiv infected
bone marrow
respiratory failure
smoking cessation
mechanical ventilation
cell therapy